| 000 | 01756 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517170415.0 | ||
| 264 | 0 | _c20180514 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1875-9777 | ||
| 024 | 7 |
_a10.1016/j.stem.2017.07.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCoombs, Catherine C | |
| 245 | 0 | 0 |
_aTherapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. _h[electronic resource] |
| 260 |
_bCell stem cell _c09 2017 |
||
| 300 |
_a374-382.e4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aClone Cells |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Association Studies |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xgenetics |
| 650 | 0 | 4 | _aHematopoiesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aZehir, Ahmet | |
| 700 | 1 | _aDevlin, Sean M | |
| 700 | 1 | _aKishtagari, Ashwin | |
| 700 | 1 | _aSyed, Aijazuddin | |
| 700 | 1 | _aJonsson, Philip | |
| 700 | 1 | _aHyman, David M | |
| 700 | 1 | _aSolit, David B | |
| 700 | 1 | _aRobson, Mark E | |
| 700 | 1 | _aBaselga, José | |
| 700 | 1 | _aArcila, Maria E | |
| 700 | 1 | _aLadanyi, Marc | |
| 700 | 1 | _aTallman, Martin S | |
| 700 | 1 | _aLevine, Ross L | |
| 700 | 1 | _aBerger, Michael F | |
| 773 | 0 |
_tCell stem cell _gvol. 21 _gno. 3 _gp. 374-382.e4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.stem.2017.07.010 _zAvailable from publisher's website |
| 999 |
_c27461416 _d27461416 |
||